OBJECTIVES: We evaluated the neurotrophic factors [nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glia-derived neurotrophic factor (GDNF)] expression and their association with the severity and outcome of children with traumatic brain injury. DESIGN: Prospective observational clinical study. SETTING: Pediatric intensive care unit. PATIENTS: Fourteen children with severe head injury; 12 controls with obstructive hydrocephalus. MEASUREMENT: Cerebrospinal fluid (CSF) and plasma samples were collected 2 h (T1) and 24 h (T2) after head injury. Neurotrophic factor levels were measured using an immuno-enzymatic assay. MAIN RESULTS: In patients, neurotrophic factor mean levels were significantly different in both CSF and plasma, showing high levels of BDNF compared to NGF and GDNF. Considering T1 and T2 expression, in the CSF the level of NGF increased from 3.5+/-0.4 pg/ml to 48.2+/-11.7 pg/ml ( p<0.001); BDNF decreased from 4854.0+/-1303.7 pg/ml to 593.0+/-114.8 pg/ml ( p<0.001), while GDNF did not undergo significant variations. In plasma, no significant changes were observed. Regarding severity and outcome, BDNF levels showed a sharp peak after head injury, but the only significant association was between NGF expression in the CSF and a good outcome versus a poor outcome ( p=0.007). CONCLUSIONS: The variations in neurotrophic factor levels reflect an endogenous attempt at neuroprotection against biochemical and molecular changes after traumatic head injury. BDNF represents an early marker of brain injury, while NGF expression in the CSF was indicative of a good outcome and the role of this neurotrophin in the treatment of children with severe head injury may be hypothesized.
OBJECTIVES: We evaluated the neurotrophic factors [nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), glia-derived neurotrophic factor (GDNF)] expression and their association with the severity and outcome of children with traumatic brain injury. DESIGN: Prospective observational clinical study. SETTING: Pediatric intensive care unit. PATIENTS: Fourteen children with severe head injury; 12 controls with obstructive hydrocephalus. MEASUREMENT: Cerebrospinal fluid (CSF) and plasma samples were collected 2 h (T1) and 24 h (T2) after head injury. Neurotrophic factor levels were measured using an immuno-enzymatic assay. MAIN RESULTS: In patients, neurotrophic factor mean levels were significantly different in both CSF and plasma, showing high levels of BDNF compared to NGF and GDNF. Considering T1 and T2 expression, in the CSF the level of NGF increased from 3.5+/-0.4 pg/ml to 48.2+/-11.7 pg/ml ( p<0.001); BDNF decreased from 4854.0+/-1303.7 pg/ml to 593.0+/-114.8 pg/ml ( p<0.001), while GDNF did not undergo significant variations. In plasma, no significant changes were observed. Regarding severity and outcome, BDNF levels showed a sharp peak after head injury, but the only significant association was between NGF expression in the CSF and a good outcome versus a poor outcome ( p=0.007). CONCLUSIONS: The variations in neurotrophic factor levels reflect an endogenous attempt at neuroprotection against biochemical and molecular changes after traumatic head injury. BDNF represents an early marker of brain injury, while NGF expression in the CSF was indicative of a good outcome and the role of this neurotrophin in the treatment of children with severe head injury may be hypothesized.
Authors: K B Nelson; J K Grether; L A Croen; J M Dambrosia; B F Dickens; L L Jelliffe; R L Hansen; T M Phillips Journal: Ann Neurol Date: 2001-05 Impact factor: 10.422
Authors: L Olson; A Nordberg; H von Holst; L Bäckman; T Ebendal; I Alafuzoff; K Amberla; P Hartvig; A Herlitz; A Lilja Journal: J Neural Transm Park Dis Dement Sect Date: 1992
Authors: M Eriksdotter Jönhagen; A Nordberg; K Amberla; L Bäckman; T Ebendal; B Meyerson; L Olson; M Shigeta; E Theodorsson; M Viitanen; B Winblad; L O Wahlund Journal: Dement Geriatr Cogn Disord Date: 1998 Sep-Oct Impact factor: 2.959
Authors: Edward Abraham; Peter Andrews; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Michael Pinsky; Peter Radermacher; Marco Ranieri; Christian Richard; Robert Tasker; Benoit Vallet Journal: Intensive Care Med Date: 2004-06-26 Impact factor: 17.440
Authors: Frederick K Korley; Ramon Diaz-Arrastia; Alan H B Wu; John K Yue; Geoffrey T Manley; Haris I Sair; Jennifer Van Eyk; Allen D Everett; David O Okonkwo; Alex B Valadka; Wayne A Gordon; Andrew I R Maas; Pratik Mukherjee; Esther L Yuh; Hester F Lingsma; Ava M Puccio; David M Schnyer Journal: J Neurotrauma Date: 2015-09-18 Impact factor: 5.269
Authors: Frank Krueger; Matteo Pardini; Edward D Huey; Vanessa Raymont; Jeffrey Solomon; Robert H Lipsky; Colin A Hodgkinson; David Goldman; Jordan Grafman Journal: J Neurosci Date: 2011-01-12 Impact factor: 6.167